GlassScriptPhysician profile
Alan M Unell
NPI 1366543621
$1,069.65
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $214 · 2021: $89.76 · 2022: $266 · 2023: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $178.04 | 2019-2020 | |
| Exeltis, USA INC. | $152.13 | 2019-2023 | Slynd |
| Astellas Pharma US INC | $115.98 | 2022-2023 | Veozah |
| Millicent US INC | $101.95 | 2019-2023 | Intrarosa |
| Mayne Pharma Commercial LLC | $80.36 | 2022-2023 | |
| Myriad Women'S Health, INC. | $68.85 | 2023 | Myrisk |
| Duchesnay USA Incorporated | $50.08 | 2019 | |
| Ascend Therapeutics US, LLC | $48.11 | 2020-2023 | |
| Abbvie INC. | $39.70 | 2019 | |
| Amag Pharmaceuticals, INC. | $39.45 | 2019 | |
| Therapeuticsmd, INC. | $36.22 | 2019-2020 | |
| Avion Pharmaceuticals | $33.34 | 2019-2022 | |
| Hologic Sales and Service, LLC | $27.62 | 2020 | |
| Becton, Dickinson and Company | $21.38 | 2021 | |
| Exact Sciences Corporation | $21.29 | 2023 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.74 | 2019 | |
| Janssen Biotech, INC. | $18.86 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Unell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.